MIGDAL HA'EMEQ, Israel, Feb. 4, 2015 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, today announced that the Company will release financial results for the fourth quarter and full year ended December 31, 2014 on Wednesday, February 18, 2015, before the market opens. Following the release, Dr. Ariel Katz, President and Chief Executive Officer, and Oren Bryan, Vice President and Chief Financial Officer will host a conference call to review the financial results.
The conference call is scheduled to begin at 8:30 a.m. ET on Wednesday, February 18, 2015. Participants should dial (877) 359-9508 (United States) or (224) 357-2393 (International) with confirmation code 80136507 to access the live call. The call will also be broadcast live over the Internet, hosted in the Investors section of Enzymotec's website at http://ir.enzymotec.com, and will be archived online within one hour of its completion through February 25, 2015.
A dial-in replay of the call will also be available to those interested until February 25, 2015. To access the replay, dial (855) 859-2056 (United States) or (404) 537-3406 (International) and enter code 80136507.
About Enzymotec Ltd.
Enzymotec Ltd. is a leading global supplier of specialty lipid-based products and solutions. The Company develops, manufactures and markets innovative bio-active lipid ingredients, as well as final products, based on sophisticated processes and technologies. For more information, visit www.enzymotec.com.
CONTACT: KCSA Strategic Communications Jeffrey Goldberger / Tram Bui 212.896.1249 / 212.896.1290 ENZY@kcsa.com